Why is Indoco Remedies Ltd ?
1
Weak Long Term Fundamental Strength with a -30.11% CAGR growth in Operating Profits over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.21 times
- The company has been able to generate a Return on Equity (avg) of 5.91% signifying low profitability per unit of shareholders funds
2
Flat results in Sep 26
- INTEREST(9M) At Rs 101.12 cr has Grown at 32.49%
- DEBTORS TURNOVER RATIO(HY) Lowest at 3.47 times
3
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -0.67% over the previous quarter and collectively hold 18.28% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -7.85% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Indoco Remedies for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Indoco Remedies
-7.85%
-0.15
52.27%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
6.23%
EBIT Growth (5y)
-30.11%
EBIT to Interest (avg)
4.41
Debt to EBITDA (avg)
4.96
Net Debt to Equity (avg)
0.99
Sales to Capital Employed (avg)
1.04
Tax Ratio
30.31%
Dividend Payout Ratio
-2.50%
Pledged Shares
0
Institutional Holding
18.28%
ROCE (avg)
8.26%
ROE (avg)
5.91%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
40
Price to Book Value
2.11
EV to EBIT
89.85
EV to EBITDA
18.75
EV to Capital Employed
1.56
EV to Sales
1.66
PEG Ratio
NA
Dividend Yield
0.09%
ROCE (Latest)
1.74%
ROE (Latest)
-7.59%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Bullish
Bullish
Technical Movement
2What is working for the Company
NET SALES(Q)
Highest at Rs 520.17 cr
-4What is not working for the Company
INTEREST(9M)
At Rs 101.12 cr has Grown at 32.49%
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.47 times
Loading Valuation Snapshot...
Here's what is working for Indoco Remedies
Net Sales - Quarterly
Highest at Rs 520.17 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Indoco Remedies
Interest - Nine Monthly
At Rs 101.12 cr has Grown at 32.49%
over preceding nine months periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Debtors Turnover Ratio- Half Yearly
Lowest at 3.47 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio